
Lupin and Natco Secure US FDA Approval for Generic Eribulin Mesylate Injection
Lupin Limited and its alliance partner Natco Pharma Limited have received approval from the United

Lupin Limited and its alliance partner Natco Pharma Limited have received approval from the United

Global pharmaceutical company Lupin Limited has been included for the first time in the Dow

Lupin Limited has announced that it has received approval from the United States Food and

Lupin Limited has announced that results from its ongoing Phase 1a clinical study evaluating LNP8701,

Lupin Limited has received approval from China’s National Medical Products Administration for its Abbreviated New

Lupin Limited announced that it has received tentative approval from the United States Food and

Global pharmaceutical company Lupin Limited has announced the inauguration of Atharv Ability, an advanced multidisciplinary

Lupin Limited has announced that it has received approval from the US Food and Drug

Lupin Limited has announced the launch of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the

Lupin Limited has been recognized with the Great Place To Work® Certification for 2026–27, reaffirming